Implementation of a lung cancer screening initiative in HIV-infected subjects.
Jorge Díaz-ÁlvarezPatricia RoizLuis GorospeAna AyalaSergio Pérez-PintoJavier Martínez-SanzMatilde Sánchez-CondeJosé Luis CasadoMaría J Pérez-ElíasAna MorenoRaquel RonMaría J VivancosPilar VizcarraSantiago MorenoSergio Serrano-VillarPublished in: PloS one (2021)
In this pilot program of low-dose computed tomography (LDCT) for the screening of lung cancer (LC) in a targeted population of people with HIV (PWH), its prevalence was 3.6%; the number needed to screen in order to detect one case of lung cancer was 28, clearly outweighing the risks associated with lung cancer screening. While data from additional cohorts with longitudinal measurements are needed, PWH are a target population for lung cancer screening with LDCT.
Keyphrases
- hiv infected
- low dose
- computed tomography
- antiretroviral therapy
- quality improvement
- primary care
- healthcare
- magnetic resonance imaging
- randomized controlled trial
- hiv positive
- hepatitis c virus
- hiv aids
- high throughput
- mass spectrometry
- study protocol
- cross sectional
- risk assessment
- simultaneous determination
- big data
- single cell
- tandem mass spectrometry
- gas chromatography